These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22017039)

  • 1. Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens.
    Ramp K; Veits J; Deckers D; Rudolf M; Grund C; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2011 Sep; 55(3):413-21. PubMed ID: 22017039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
    Veits J; Wiesner D; Fuchs W; Hoffmann B; Granzow H; Starick E; Mundt E; Schirrmeier H; Mebatsion T; Mettenleiter TC; Römer-Oberdörfer A
    Proc Natl Acad Sci U S A; 2006 May; 103(21):8197-202. PubMed ID: 16717197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.
    Cornelissen LA; de Leeuw OS; Tacken MG; Klos HC; de Vries RP; de Boer-Luijtze EA; van Zoelen-Bos DJ; Rigter A; Rottier PJ; Moormann RJ; de Haan CA
    PLoS One; 2012; 7(8):e44447. PubMed ID: 22952980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
    Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
    J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector.
    Murr M; Grund C; Breithaupt A; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2020 Dec; 64(4):427-436. PubMed ID: 33347549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Newcastle disease virus recombinant expressing avian influenza virus H6 hemagglutinin against Newcastle disease and low pathogenic avian influenza in chickens and turkeys.
    Schröer D; Veits J; Keil G; Römer-Oberdörfer A; Weber S; Mettenleiter TC
    Avian Dis; 2011 Jun; 55(2):201-11. PubMed ID: 21793434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity.
    Nayak B; Kumar S; DiNapoli JM; Paldurai A; Perez DR; Collins PL; Samal SK
    J Virol; 2010 Mar; 84(5):2408-20. PubMed ID: 20032181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.
    Nayak B; Rout SN; Kumar S; Khalil MS; Fouda MM; Ahmed LE; Earhart KC; Perez DR; Collins PL; Samal SK
    PLoS One; 2009 Aug; 4(8):e6509. PubMed ID: 19654873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens.
    Kim SH; Paldurai A; Xiao S; Collins PL; Samal SK
    Vaccine; 2014 Jul; 32(35):4428-4435. PubMed ID: 24968158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of insertion site of the avian influenza virus haemagglutinin (HA) gene within the Newcastle disease virus genome on HA expression.
    Ramp K; Skiba M; Karger A; Mettenleiter TC; Römer-Oberdörfer A
    J Gen Virol; 2011 Feb; 92(Pt 2):355-60. PubMed ID: 21068215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.
    Murr M; Karger A; Steglich C; Mettenleiter TC; Römer-Oberdörfer A
    J Gen Virol; 2020 May; 101(5):473-483. PubMed ID: 32209169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
    Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
    Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.